Zits After Zoster? Unmasking Postherpetic Comedones
"A Deep Dive into the Rare Skin Condition Linking Shingles and Unexpected Breakouts"
Shingles, caused by the varicella-zoster virus (VZV), can leave behind more than just lingering nerve pain. In some rare cases, it can trigger a skin phenomenon known as Wolf's postherpetic isotopic response (PHIR), leading to the development of new skin lesions in the area previously affected by the herpes zoster infection. While PHIR can manifest in various ways, one of the less common presentations is the appearance of comedones – better known as pimples or blackheads.
Although the link between VZV and subsequent skin conditions has been recognized, the occurrence of comedones following a shingles outbreak remains relatively rare. A review of medical literature reveals only a handful of reported cases. This makes each new case important for understanding the complexities of how our skin responds to viral infections and heals afterward.
This article delves into two unusual cases of postherpetic comedones observed in Chinese Han patients. By exploring these cases, we'll shed light on the possible mechanisms behind this phenomenon and offer insights into managing this unexpected dermatological twist.
Shingles and PHN: Recent U.S. Figures
The CDC’s shingles data resource, updated April 12, 2024, covers U.S. shingles burden, risk groups, and data trends. A 2024 study reported that herpes zoster and postherpetic neuralgia (PHN) incidence decreased during the COVID-19 pandemic from 2019 to 2021. One source estimates that about 10–30% of people who develop shingles go on to develop PHN, with the proportion varying by age and the time point measured. A separate U.S. 2025 statistics source reports shingles incidence ranging from 1.2 per 1,000 people among ages 20–29 to 32.6 per 1,000 among those 80 and older.
From Long-Known Illness to Vaccination
A 2026 historical overview describes shingles as affecting humans for thousands of years and traces changing understanding from an ancient mystery to modern vaccines. A 2007 review states that a zoster vaccine was indicated for adults aged 60 years and older and had been shown to reduce zoster incidence and severity, as well as PHN incidence, in that population. The review also notes that shingles continued to be seen frequently in clinical practice despite vaccine availability.
Decoding Postherpetic Comedones: What's Happening?
Postherpetic comedones are thought to arise from a disruption in the skin's local environment following a shingles infection. Here's a breakdown of the key factors:
- Immune System Imbalance: Viral infections can temporarily alter the balance of the skin's immune system. Some research suggests that the number of Langerhans cells, which help regulate immune responses in the skin, may be reduced after a shingles infection.
- Disrupted Homeostasis: The combination of nerve damage and immune system changes can disrupt the skin's natural equilibrium, potentially leading to abnormal follicular function and the formation of comedones.
- Other Factors: Age, genetics, and individual skin characteristics may also play a role in the development of postherpetic comedones.
Postherpetic Comedones in Context
The article “Zits After Zoster? Unmasking Postherpetic Comedones” describes these lesions as pimples or blackheads that can appear in skin previously affected by shingles. It characterizes postherpetic comedones as rare and links their development in the affected area to varicella-zoster virus (VZV). A 2026 AAFP source describes shingles as VZV reactivation that commonly causes a painful vesicular rash resolving within weeks. A 2025 review covers herpes zoster mechanisms, clinical manifestations, diagnosis, treatment, epidemiology, immunization, and adverse effects including PHN.
Mechanism Remains Unclear
A report on postherpetic comedones in two Chinese Han patients states that the exact molecular mechanism remains unknown. The authors suggest careful immunoprofiling of postherpetic lesions as a next step toward understanding this spectrum of disorders. The source therefore presents a proposed research direction rather than an established explanation for how the comedones form.
Guideline Care and a Comedone Case
The S2k herpes zoster guidelines address antiviral therapy for herpes zoster and PHN, pain management, and topical treatment options. In a 2023 case report of post-herpetic zosteriform comedones, histopathology showed a large dilated follicular canal containing orthokeratotic stratum corneum, consistent with a closed comedone. The patient was prescribed oral isotretinoin 20 mg and topical tretinoin 0.05% cream with a moisturizer, with regular follow-up requested. These sources describe different clinical angles: general zoster and pain-management guidance versus treatment reported for an individual comedone case.
The Takeaway: Shingles Doesn't Have to Mean Surprise Zits
While postherpetic comedones are an uncommon consequence of shingles, understanding the potential link can help individuals and healthcare providers be more vigilant. If you've had shingles and notice unusual breakouts in the affected area, it's worth exploring the possibility of postherpetic comedones with a dermatologist.
Reported Cases and Possible Risk Factors
A JAMA Dermatology report describes seven cases involving different degrees of postherpetic comedogenesis. After the first two cases were observed, routine follow-up of herpes zoster was adjusted to include specific assessment for follicular plugging. A 2023 analysis of skin lesions after shingles identified age 60 years or older, severe skin injury combined with diabetes, low immune function, scar history, and squeezing or stripping as independent risk factors for skin lesions due to shingles.
Vaccination and the Burden of Shingles
A study of recombinant herpes zoster vaccine effectiveness in Japan notes that the two-dose vaccine has been available there since 2020, while coverage remains low because vaccination is voluntary. The study investigated real-world effectiveness for preventing herpes zoster using clinical databases. A separate educational case describes Betty, a fictitious name assigned to a real 77-year-old patient with COPD and a 30 pack-year smoking history, who experienced shingles and PHN. Another source characterizes PHN as often refractory to treatment and disruptive to patients’ lives.
Diagnosis typically involves a clinical examination. A doctor will assess the lesions and consider your medical history, especially any prior shingles infections. They'll also rule out other conditions that can cause comedones, such as acne or Favre-Racouchot syndrome.
While research is ongoing to fully understand the mechanisms behind postherpetic comedones, current treatments focus on managing the symptoms. These may include topical retinoids, comedone extraction, and other acne-fighting therapies. A dermatologist can recommend the most appropriate approach for your specific case.